Melissa Gomez

A dynamic healthcare communications strategist with over 15 years of experience, she stands at the intersection of healthcare innovation and strategic communication. Her impressive portfolio showcases partnerships with pharmaceutical giants including Roche, Janssen, Bayer, Sanofi, Alcon, Novartis, and Gilead, as well as prestigious healthcare institutions such as the University of Miami Health System, Houston Methodist Hospital, Baptist Health South Florida, and MD Anderson.

As a reputation management expert, she excels in crafting compelling thought leadership narratives and executive positioning strategies. Her work extends beyond traditional communications, encompassing global health awareness campaigns executed in collaboration with prominent NGOs, patient advocacy groups, and professional associations. Her expertise in medical communications shines through her management of scientific symposia, advisory boards, and key opinion leader media trainings, alongside the development of authoritative white papers and scientific publications.

Her exceptional work has garnered industry recognition, notably through a prestigious 2018 SABRE Awards Latin America in the Multi-market category for a Roche project while at Edelman. The same project earned a Certificate of Excellence in Superior Achievement in Reputation Management and was shortlisted for the Platinum SABRE.

With deep expertise across various therapeutic areas - including oncology, hemophilia, ophthalmology, women's health, infectious diseases, and hematology - she has cultivated enduring relationships with healthcare professionals, patients, and advocates within these specialized communities. Her multicultural background as a Colombian-born, Texas-raised professional enables her to seamlessly navigate both English and Spanish-speaking environments.

Her academic credentials include a B.S. in Public Relations and a certificate in business foundations from The University of Texas at Austin. Further enhancing her healthcare expertise, she completed specialized studies at the Harvard T.H. Chan School of Public Health Healthcare, focusing on Quality of Life: Beyond the Frontiers of IT and System Changes.